Catalyst Biosciences - 48 Year Dividend History | CBIO

Historical dividend payout and yield for Catalyst Biosciences (CBIO) since 1971. The current TTM dividend payout for Catalyst Biosciences (CBIO) as of June 26, 2019 is $0.00. The current dividend yield for Catalyst Biosciences as of June 26, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.091B $0.000B
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.497B 12.72
Gilead Sciences (GILD) United States $87.305B 10.60
Bio-Techne Corp (TECH) United States $7.705B 52.57